SOUTH SAN FRANCISCO, Calif.,
May 24, 2021 /PRNewswire/
-- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic
lethality-focused precision medicine oncology company committed to
the discovery and development of targeted therapeutics, announced
its participation at the 2021 Jefferies Virtual Healthcare
Conference.
2021 Jefferies Virtual Healthcare Conference
Fireside Chat with Maury
Raycroft
Thursday, June 3, 2021 at
1:00 pm ET
A live audio webcast of the event will be available by visiting
the "Investors/News and Events/Investor Calendar" section of the
IDEAYA website at https://ir.ideayabio.com/events. A replay
of the webcast will be available for 30 days following the live
event.
About IDEAYA Biosciences
IDEAYA is a synthetic lethality-focused precision medicine
oncology company committed to the discovery and development of
targeted therapeutics for patient populations selected using
molecular diagnostics. IDEAYA's approach integrates
capabilities in identifying and validating translational biomarkers
with drug discovery to select patient populations most likely to
benefit from its targeted therapies. IDEAYA is applying its
early research and drug discovery capabilities to synthetic
lethality – which represents an emerging class of precision
medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements,
including, but not limited to, statements related to participation
in and/or presentation at certain investor relations events. IDEAYA
undertakes no obligation to update or revise any forward-looking
statements. For a further description of the risks and
uncertainties that could cause actual results to differ from those
expressed in these forward-looking statements, as well as risks
relating to the business of IDEAYA in general, see IDEAYA's
Quarterly Report on Form 10-Q filed on May
10, 2021 and any current and periodic reports filed with the
U.S. Securities and Exchange Commission.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ideaya-biosciences-to-present-at-2021-jefferies-virtual-healthcare-conference-301297342.html
SOURCE IDEAYA Biosciences, Inc.